Eva A. Karpanou

Regression of left ventricular hypertrophy results in improvement of QT dispersion in patients with hypertension

OBJECTIVES Increased QT dispersion has been considered as predisposing to ventricular arrhythmias in hypertrophic cardiomyopathy, congestive heart failure, and coronary artery disease. An increased QT dispersion has also been found in hypertensive patients with left ventricular hypertrophy (LVH). The data on the effect of LVH regression on QT dispersion are limited. METHODS AND RESULTS To assess the relation of LVH regression and QT dispersion decrease, 68 patients (42 men and 26 women, mean age 56.3+/-9.5 years) with uncomplicated essential hypertension were studied. All underwent full electrocardiographic and echocardiographic studies at baseline and after 6 months of monotherapy, 29 with angiotensin-converting enzyme inhibitors and 39 with calcium antagonists. QT dispersion was calculated by subtracting the shortest QT from the longest QT, in absolute value (QTmax - QTmin). It was also corrected with Bazetts formula (QTc dispersion). Left ventricular mass index was assessed according to the Devereux formula. After treatment, LVH decreased with both angiotensin-converting enzyme inhibitors (from 155 to 130 g/m2, P < .001) and calcium antagonists (156 to 133/92/m2, P < .001). QT dispersion decreased both after angiotensin-converting enzyme inhibitor treatment (from 82 to 63 ms) and calcium antagonist treatment (from 77 to 63 ms, both P < .001 ). There was a significant correlation of QT dispersion and left ventricular mass after therapy (r = 0.36, P < .005). There was a correlation of the degree of LVH and QT dispersion decrease (r = 0.27, P < .05). CONCLUSIONS It is concluded that LVH regression influences AQT favorably. Its prognostic value has yet to be determined.

Differential impact of metabolic syndrome on arterial stiffness and wave reflections: Focus on distinct definitions

BACKGROUND Arterial stiffness and wave reflections are independent predictors of cardiovascular disease. Metabolic syndrome (MS) is related to increased aortic stiffness in several populations. However, it is unclear whether the association of MS with aortic stiffness differs according to the considered definition. Moreover, data regarding the association of wave reflections with MS are limited. For this purpose, we examined the relationship of arterial stiffness and wave reflections with MS by using four current definitions and a score. METHODS We studied 732 never treated, non-diabetic hypertensive patients. Metabolic syndrome was defined by Adult Treatment Panel III, American Heart Association, World Health Organization (WHO), International Diabetes Federation criteria and MS (GISSI) score. Arterial stiffness was assessed by measuring carotid-femoral pulse wave velocity (PWVc-f). Heart rate-corrected augmentation index (AIx(75)) was estimated as a measure of wave reflections. RESULTS By all definitions, hypertensive patients with MS had higher PWVc-f compared to hypertensives without MS. On the contrary, no significant difference was observed in AIx(75) between patients with and those without MS except when MS was defined by WHO criteria. An independent association emerged between PWVc-f and GISSI score and MS components (p=0.038 and 0.033 respectively) in patients with MS, after adjustment for age, gender, LDL cholesterol and smoking. Nevertheless, after further adjustment for systolic blood pressure or body mass index, the strength of this association was reduced to a non-significant level. CONCLUSION Arterial stiffness is increased in patients with metabolic syndrome irrespective of the definition criteria. On the contrary, metabolic syndrome has no effect on wave reflections, except when this is defined by WHO criteria. Regarding the high prognostic significance of both arterial stiffness and wave reflections, these findings might have important clinical implications.

Nocturnal blood pressure fall and metabolic syndrome score in hypertensive patients.

BackgroundData relating dipping status to metabolic syndrome (MS) scores are not available. The purpose of this study is to investigate any possible association of different dipping patterns to MS scores in untreated patients with essential hypertension. MethodsThe study included 6256 consecutive, treatment-naive patients with essential hypertension who attended our outpatient clinics. All underwent repeated office blood pressure measurements, 24-h ambulatory blood pressure monitoring, and full clinical and laboratory evaluation. The diagnosis of MS was made according to the Adult Treatment Panel III criteria and patients were classified into five groups: group I (hypertension), group II (hypertension+any one component), group III (hypertension+any two components), group IV (hypertension+any three components), and group V (all five components). Dipping pattern was defined as ‘dippers’ with nocturnal systolic blood pressure (NSBP) falling ≥10 but <20%, ‘nondippers’ with NSBP falling ≥0% but <10%, ‘extreme dippers’ with NSBP falling ≥20%, and ‘reverse dippers’ with NSBP increasing. ResultsHypertensive patients with MS (n=2573) had higher clinical and ambulatory blood pressure values (P<0.001), whereas the dominant dipping pattern in the non-MS group was nondippers (47.6%), and in the MS group, extreme dippers (37.8%). Furthermore, a considerable decrease in the prevalence of dippers was noticed with the increasing number of MS components (21.1 vs. 19.2 vs. 14.5 vs. 8.4 vs. 7.2%, P<0.001). In contrast, a significant rise in the prevalence of reverse dippers was observed with the increasing number of MS components (7.4 vs. 10.1 vs. 14.9 vs. 20.4 vs. 31.2%, P<0.001). ConclusionsIt seems that hypertensive patients have an increased prevalence of abnormal dipping patterns as the number of MS components rises.

Impact of abnormal nocturnal blood pressure fall on vascular function

BACKGROUND It is well known that nondipping pattern of arterial hypertension has a harmful effect on target organs such as the brain, heart, and kidneys. However, it remains uncertain whether abnormal dipping patterns of nocturnal blood pressure (BP), such as extreme and reverse dipping, influence vascular function. METHODS This study comprised consecutive 2800 individuals (1554 men and 1246 women). All were nondiabetic and had uncomplicated, untreated essential sustained hypertension based on office measurements. After a 2-week wash-out period, 24-h ambulatory BP recordings were obtained and patients were classified by their nocturnal systolic BP fall (132 extreme dippers with >20% nocturnal systolic BP fall; 1235 dippers with >10% but <20% fall; 1146 nondippers with >0% but <10% fall; and 287 reverse dippers with <0% fall). Microalbumin, ACR (albumin/creatinine ratio), and microglobulin values were measured in all groups. RESULTS Extreme dippers did not differ from dippers with regard to microalbumin, microglobulin excretion, or ACR. On the contrary, reverse dippers had significantly (P <.0001) higher values, compared with nondippers, for microalbumin (49.5 v 37.2 mg/dL), microglobulin (10.33 v 8.71 mg/dL), ACR (104.9 v 65.2), and percentages of abnormal values for these parameters. CONCLUSIONS Microalbuminuria, an index of vascular function, differentiates reverse dippers from nondippers, but not extreme dippers from dippers among hypertensive patients.

Nocturnal blood pressure fall and metabolic syndrome score in patients with white coat hypertension.

BackgroundAccumulating data report that white coat hypertension (WCH) is associated with target organ damage. Metabolic syndrome (MS), and nondipping pattern is also associated with increased cardiovascular risk. The purpose of this study was to explore the nocturnal blood pressure fall in WCH patients according to their MS score. MethodsThe study comprised 2300 patients with WCH who attended our outpatient clinics. All underwent repeated office blood pressure measurements, 24-h ambulatory blood pressure monitoring, full clinical and laboratory evaluation. The diagnosis of MS was made according to the Adult Treatment Panel III criteria and patients were classified into five groups: group I (hypertension), group II (hypertension and any one component), group III (hypertension and any two components), group IV (hypertension and any three components), and group V (all five components). Dipping pattern was defined as ‘dippers’ with nocturnal systolic blood pressure (NSBP) fall greater than or equal to 10% but less than 20%, ‘nondippers’ with NSBP fall greater than or equal to 0% but less than 10%, ‘extreme dippers’ with NSBP fall greater than or equal to 20%, and ‘reverse dippers’ with NSBP increase. ResultsPatients were divided into two groups according to the presence (n=522) and absence (n=1778) of MS. The overall prevalence of MS in the study population was 22.7%. Comparing the non-MS group with the MS we observed significant differences for nondippers (24.5% vs. 38.9%, P<0.001), dippers (54.4% vs. 43.5%, P<0.001), extreme dippers (17.8% vs. 11.3%, P<0.001), and reverse dippers (3.3% vs. 6.3%, P=0.007). ConclusionPatients with WCH and increased number of MS components present with elevated nighttime SBP levels. This observation is of a great significance in the assessment of the cardiovascular risk in these patients.

Urine Albumin Excretion, Within Normal Range, Reflects Increasing Prevalence of Metabolic Syndrome in Patients With Essential Hypertension

J Clin Hypertens(Greenwich). 2010;12:597–602.

Significance of arterial hypertension on coronary collateral circulation development and left ventricular function in coronary artery disease

To assess the role of arterial hypertension in the development of coronary collateral circulation in relation to coronary artery disease, severity and left ventricular function, we studied 433 men with angiographically documented coronary artery disease. Of these, 122 showed disease in one vessel, 157 showed disease in two vessels and 159 patients showed disease in three vessels; 153 (35.3%) patients had arterial hypertension. The hypertensive patients had a similar distribution of diseased coronary vessels and similar coronary obstruction scores according to Gensini compared with the normotensive patients (64 versus 62, NS), but they had higher left ventricular ejection fraction values (51.5 versus 46.8%, P = 0.002). Coronary collateral circulation was more often seen in hypertensives (70.6 versus 57.1%, P = 0.006), especially high-grade coronary collateral circulation (27 versus 15%, P = 0.001). However, patients with coronary collateral circulation had more severe coronary artery disease, whether they had arterial hypertension (71 versus 46, P = 0.00008) or not (76 versus 43, P < 0.00001). Thus, for a similar severity of coronary artery disease, patients with arterial hypertension and also coronary collateral circulation had higher ejection fraction values (52.6 versus 46.1%, P = 0.0006). This was more readily observed in those patients with disease in three vessels and coronary collateral circulation (52 versus 42.8%, P = 0.002). Patients without coronary collateral circulation had similar ejection fraction and coronary obstruction score values, irrespective of arterial hypertension. The ejection fraction corrected for coronary artery disease was significantly (P < 0.00001) related to the extent of coronary collateral circulation in normotensives (r = 0.36), and more so in hypertensives (r = 0.4). It is concluded that patients with coronary artery disease more often develop coronary collateral circulation in the presence of arterial hypertension, thus preserving left ventricular function for similar obstructive coronary lesions.

Left ventricular hypertrophy regression and function changes with ketanserin in elderly hypertensives.

SummaryKetanserin is a serotonin antagonist with age-related antihypertensive efficacy. Its effects on left ventricular (LV) function and hypertrophy have not been adequately reported. We studied noninvasively 54 elderly hypertensives before and 6 months after ketanserin monotherapy. Mean blood pressure was controlled (174/101 to 145/86 mmHg, p<0.0001) with no heart rate changes. LV dimensions and volumes remained unchanged, as did all LV ejection indices, thus preserving LV output (p=ns). Total peripheral resistances fell (from means of 1986 to 1615 dynes, cm.s-5, p<0.0001), as did LV systolic wall stresses. Mean LV mass was reduced (248 to 237 g, p<0.0001), mainly due to interventricular septum thinning (11.8 to 11.1 mm, p<0.0001), resulting in a decrease in mean LV cross-sectional area (21.3 to 20.5 cm2, p<0.0001) and mass/volume ratio (2.14 to 2.01 p=0.0001). Thus, LV hypertrophy regression did not affect contractility (LV mass index relation to stress/end-systolic volume index, r=−0.558 before and r=−0.564 after ketanserin therapy). It is concluded that ketanserin is an effective antihypertensive agent in the elderly that reduces LV hypertrophy indices and maintains cardiac output, with no concomitant burdening on LV hemodynamics.

Prostate‐Specific Antigen Levels Are Associated with Arterial Stiffness in Essential Hypertensive Patients

INTRODUCTION Prostate-specific antigen (PSA) has been recently related to cardiovascular system in a multifactorial way. Arterial stiffness is a independent predictor of cardiovascular events and is involved in the pathogenesis of hypertension. The aim of the present study was to investigate whether PSA values, are associated with arterial stiffness indices in patients with essential arterial hypertension. METHODS The study comprised 150 consecutive male patients (mean age 60 years) with uncomplicated never-treated essential hypertension. All patients underwent a complete clinical and laboratory evaluation, including measurement of PSA levels. Aortic stiffness and arterial wave reflection assessment was made by using carotid-femoral (PWVc-f) pulse wave velocity and aortic augmentation index corrected for heart rate (AIx75). Patients with prostate cancer or benign prostate hyperplasia (PSA > 4 ng/mL) were excluded from the study. RESULTS PSA was positively associated with waist-to-hip ratio (r = 0.235, P = 0.04), PWVc-f (r = 0.426, P < 0.001), AIx75 (r = 0.264, P = 0.001), and high sensitivity C-reactive protein (hsCRP; r = 0.376, P < 0.001). In categorization to PSA quartiles, patients in the higher quartile presented with higher waist-to hip ratio (P = 0.009), PWVc-f (P < 0.00001), AIx75 (P < 0.001) and hsCRP (P < 0.001) values. In multivariate analysis after adjustment for various confounders PSA remained a significant determinant of PWVc-f values (beta [SE] = 0.477 [0.13], R(2) = 0.405, P < 0.001). CONCLUSION The present study points towards an association between PSA levels and aortic stiffness in untreated essential hypertensive males. Potential causal relationships between PSA and arterial stiffness remain to be further explored.

Correlation of 24-Hour Blood Pressure and Heart Rate Variability to Renal Function Parameters in Hypertensive Patients. The Effect of Smoking

Intrarenal hemodynamics depend on blood pressure (BP), heart rate (HR), and smoking. Although BP levels have been associated with kidney function, the effect of HR levels, BP, and HR variability on renal function are less well clarified. This cross‐sectional study sought to determine the association of 24‐hour BP and HR variability with kidney function in hypertensive patients, stratified by smoking. The study comprised 9600 nondiabetic, never‐treated hypertensive individuals without evident renal impairment examined from 1985 to 2014 (aged 53.3±13.4 years, 55.3% males). The 24‐hour systolic BP (SBP) and HR variability were estimated via their coefficient of variation (CV=standard deviation×100/mean value) derived from ambulatory recording. The CVSBP‐to‐CVHR ratio (CVR) was used as a marker of the interplay between 24‐hour SBP and HR variability. Renal function was estimated via 24‐hour urine creatinine clearance (CrCl), estimated glomerular filtration rate (eGFR), albumin‐to‐creatinine ratio (ACR), and 24‐hour urine α1‐microglobulin. After adjustment for age, sex, and smoking, CVSBP was found to be weakly correlated to eGFR (r=−0.017, P=.1) and somewhat more strongly to CrCl, ACR, and α1‐microglobulin (r=−0.032, 0.072, and 0.065; P=.002, <.001 and <.001, respectively). CVHR was much better related to renal function, with stronger adjusted correlations to CrCl, eGFR, ACR, and α1‐microglobulin (r=0.185, 0.134, −0.306, −0.247; all P<.001, respectively). CVR also showed equally good adjusted correlations (r=−0.175, −0.125, 0.336, 0.262; all P<.001, respectively). Most adjusted correlations for CVHR and CVR were even better in smokers (r=0.213, 0.158, −0.332, −0.272 and −0.183, −0.118, 0.351, 0.275, respectively; all P<.001). CVHR and CVR emerge as better related to kidney function than CVSBP, especially in smokers. The correlation of CVHR and CVSBP to renal function is inverse to each other. ACR and α1‐microglobulin are better related to variability indices than CrCl and eGFR. However, causal relations cannot be proved.